Article Text

Download PDFPDF
B type natriuretic peptide testing: where are we now?
  1. M R Cowie
  1. Correspondence to:
    Professor Martin R Cowie
    National Heart & Lung Institute, Imperial College, London SW3 6LY, UK; m.cowieimperial.ac.uk

Abstract

It is possible that plasma BNP measurement might be to heart failure what glycated haemoglobin measurement is to diabetes mellitus. Indeed, within 12–24 months, BNP testing might become a routine addition to the monitoring of patients with heart failure. In the meantime its main role is in helping to rule out heart failure in patients with new symptoms

  • ACS, acute coronary syndrome
  • BATTLE, SCARRED
  • BNP, assisted treatment to lessen serial cardiovascular readmissions and dealth
  • BNP, B type natriuretic peptide
  • MONICA, monitoring trends and determinants in cardiovascular disease
  • NICE, National Institute for Clinical Excellence
  • NTproBNP, N terminal proBNP
  • ROC, receiver operating characteristic
  • STARS, suivi du traitement dans I’insuffisance cardiaque systolique
  • B type natriuretic peptide
  • BNP
  • heart failure

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Miscellanea
    BMJ Publishing Group Ltd and British Cardiovascular Society
  • Miscellanea
    BMJ Publishing Group Ltd and British Cardiovascular Society
  • Miscellanea
    BMJ Publishing Group Ltd and British Cardiovascular Society